Abbott Laboratories Net Worth

Abbott Laboratories Net Worth Analysis

Abbott Laboratories Target Price Consensus

Abbott Laboratories Target Price Projection

Abbott Laboratories' current and average target prices are 123.67 and 140.81, respectively. The current price of Abbott Laboratories is the price at which Abbott Laboratories is currently trading. On the other hand, Abbott Laboratories' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Abbott Laboratories and the information provided on this page.

Know Abbott Laboratories' Top Institutional Investors

Note, although Abbott Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Abbott Laboratories' market capitalization trends

The company currently falls under 'Mega-Cap' category with a total capitalization of 215.17 B.

Project Abbott Laboratories' profitablity

The company has Net Profit Margin of 0.32 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Abbott Laboratories' management efficiency

Abbott Laboratories has Return on Asset of 0.0638 % which means that on every $100 spent on assets, it made $0.0638 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3065 %, implying that it generated $0.3065 on every 100 dollars invested. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.17 in 2025. Return On Capital Employed is likely to drop to 0.1 in 2025. At this time, Abbott Laboratories' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 4.2 B in 2025, whereas Total Current Liabilities is likely to drop slightly above 8.5 B in 2025.

Abbott Laboratories Corporate Filings

Abbott Laboratories time-series forecasting models is one of many Abbott Laboratories' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Abbott Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Abbott Laboratories Earnings Estimation Breakdown

The calculation of Abbott Laboratories' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Abbott Laboratories is estimated to be 1.3 with the future projection ranging from a low of 1.21 to a high of 1.39. Please be aware that this consensus of annual earnings estimates for Abbott Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.

Abbott Laboratories Earnings Projection Consensus

Abbott Laboratories Earnings History

Earnings estimate consensus by Abbott Laboratories analysts from Wall Street is used by the market to judge Abbott Laboratories' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Abbott Laboratories' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. At this time, Abbott Laboratories' Retained Earnings are comparatively stable compared to the past year. Earnings Yield is likely to gain to 0.09 in 2025, whereas Retained Earnings Total Equity is likely to drop slightly above 27.2 B in 2025. Net Income Applicable To Common Shares is likely to gain to about 8.4 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 1.3 B in 2025.

Hype Prediction Low Estimated High 122.10 123.66 125.22 Details

Intrinsic Valuation Low Real High 115.84 117.40 136.04 Details

Naive Forecast Low Next High 118.03 119.59 121.15 Details

28 Analysts Consensus Low Target High 128.14 140.81 156.30 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Abbott Laboratories. Your research has to be compared to or analyzed against Abbott Laboratories' peers to derive any actionable benefits. When done correctly, Abbott Laboratories' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Abbott Laboratories. Note that many institutional investors and large investment bankers can move markets due to the volume of Abbott assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Abbott Laboratories. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Abbott Laboratories' stock price in the short term.

Abbott Laboratories Earnings per Share Projection vs Actual

Actual Earning per Share of Abbott Laboratories refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Abbott Laboratories predict the company's earnings will be in the future. The higher the earnings per share of Abbott Laboratories, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Abbott Laboratories Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Abbott Laboratories, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Abbott Laboratories should always be considered in relation to other companies to make a more educated investment decision.

Abbott Quarterly Analyst Estimates and Surprise Metrics

Abbott Laboratories Corporate Directors

Already Invested in Abbott Laboratories?

Additional Tools for Abbott Stock Analysis